Arrivent Biopharma Inc (AVBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Operating Expenses | 94,308 | 74,590 | 36,906 | 51,606 |
| Operating Income | -94,308 | -74,590 | -36,906 | -51,606 |
| Other Income | 13,820 | 5,257 | 0 | 0 |
| Pre-tax Income | -80,488 | -69,333 | -36,906 | -51,606 |
| Net Income Continuous | -80,488 | -69,333 | -36,906 | -51,606 |
| Net Income | $-80,488 | $-69,333 | $-36,906 | $-51,606 |
| EPS Basic Total Ops | -2.56 | -32.38 | -28.90 | -72.56 |
| EPS Basic Continuous Ops | -2.56 | -32.38 | -28.90 | -72.58 |
| EPS Diluted Total Ops | -2.56 | -32.38 | -28.90 | -72.56 |
| EPS Diluted Continuous Ops | -2.56 | -32.38 | -28.90 | -72.58 |
| EPS Diluted Before Non-Recurring Items | -2.55 | -32.38 | N/A | N/A |
| EBITDA(a) | $-94,308 | $-74,590 | $-36,906 | $-51,606 |